| |
Public Act 096-1285 Public Act 1285 96TH GENERAL ASSEMBLY |
Public Act 096-1285 | HB6459 Enrolled | LRB096 21101 RLC 36952 b |
|
| AN ACT concerning criminal law.
| Be it enacted by the People of the State of Illinois, | represented in the General Assembly:
| Section 5. The Illinois Controlled Substances Act is | amended by changing Section 204 as follows: | (720 ILCS 570/204) (from Ch. 56 1/2, par. 1204) | Sec. 204. (a) The controlled substances listed in this | Section are
included in Schedule I. | (b) Unless specifically excepted or unless listed in | another
schedule, any of the following opiates, including their | isomers,
esters, ethers, salts, and salts of isomers, esters, | and ethers,
whenever the existence of such isomers, esters, | ethers and salts is
possible within the specific chemical | designation: | (1) Acetylmethadol; | (1.1) Acetyl-alpha-methylfentanyl | (N-[1-(1-methyl-2-phenethyl)-
| 4-piperidinyl]-N-phenylacetamide); | (2) Allylprodine; | (3) Alphacetylmethadol, except
| levo-alphacetylmethadol (also known as levo-alpha-
| acetylmethadol, levomethadyl acetate, or LAAM); | (4) Alphameprodine; |
| (5) Alphamethadol; | (6) Alpha-methylfentanyl
| (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
| propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-
| propanilido) piperidine; | (6.1) Alpha-methylthiofentanyl
| (N-[1-methyl-2-(2-thienyl)ethyl-
| 4-piperidinyl]-N-phenylpropanamide); | (7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP); | (7.1) PEPAP
| (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine); | (8) Benzethidine; | (9) Betacetylmethadol; | (9.1) Beta-hydroxyfentanyl
| (N-[1-(2-hydroxy-2-phenethyl)-
| 4-piperidinyl]-N-phenylpropanamide); | (10) Betameprodine; | (11) Betamethadol; | (12) Betaprodine; | (13) Clonitazene; | (14) Dextromoramide; | (15) Diampromide; | (16) Diethylthiambutene; | (17) Difenoxin; | (18) Dimenoxadol; | (19) Dimepheptanol; |
| (20) Dimethylthiambutene; | (21) Dioxaphetylbutyrate; | (22) Dipipanone; | (23) Ethylmethylthiambutene; | (24) Etonitazene; | (25) Etoxeridine; | (26) Furethidine; | (27) Hydroxpethidine; | (28) Ketobemidone; | (29) Levomoramide; | (30) Levophenacylmorphan; | (31) 3-Methylfentanyl
| (N-[3-methyl-1-(2-phenylethyl)-
| 4-piperidyl]-N-phenylpropanamide); | (31.1) 3-Methylthiofentanyl
| (N-[(3-methyl-1-(2-thienyl)ethyl-
| 4-piperidinyl]-N-phenylpropanamide); | (32) Morpheridine; | (33) Noracymethadol; | (34) Norlevorphanol; | (35) Normethadone; | (36) Norpipanone; | (36.1) Para-fluorofentanyl
| (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
| 4-piperidinyl]propanamide); | (37) Phenadoxone; |
| (38) Phenampromide; | (39) Phenomorphan; | (40) Phenoperidine; | (41) Piritramide; | (42) Proheptazine; | (43) Properidine; | (44) Propiram; | (45) Racemoramide; | (45.1) Thiofentanyl
| (N-phenyl-N-[1-(2-thienyl)ethyl-
| 4-piperidinyl]-propanamide); | (46) Tilidine; | (47) Trimeperidine; | (48) Beta-hydroxy-3-methylfentanyl (other name:
| N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
| N-phenylpropanamide). | (c) Unless specifically excepted or unless listed in | another
schedule, any of the following opium derivatives, its | salts, isomers
and salts of isomers, whenever the existence of | such salts, isomers and
salts of isomers is possible within the | specific chemical designation: | (1) Acetorphine; | (2) Acetyldihydrocodeine; | (3) Benzylmorphine; | (4) Codeine methylbromide; | (5) Codeine-N-Oxide; |
| (6) Cyprenorphine; | (7) Desomorphine; | (8) Diacetyldihydromorphine (Dihydroheroin); | (9) Dihydromorphine; | (10) Drotebanol; | (11) Etorphine (except hydrochloride salt); | (12) Heroin; | (13) Hydromorphinol; | (14) Methyldesorphine; | (15) Methyldihydromorphine; | (16) Morphine methylbromide; | (17) Morphine methylsulfonate; | (18) Morphine-N-Oxide; | (19) Myrophine; | (20) Nicocodeine; | (21) Nicomorphine; | (22) Normorphine; | (23) Pholcodine; | (24) Thebacon. | (d) Unless specifically excepted or unless listed in | another
schedule, any material, compound, mixture, or | preparation which contains
any quantity of the following | hallucinogenic substances, or which
contains any of its salts, | isomers and salts of isomers, whenever the
existence of such | salts, isomers, and salts of isomers is possible
within the | specific chemical designation (for the purposes of this
|
| paragraph only, the term "isomer" includes the optical, | position and
geometric isomers): | (1) 3,4-methylenedioxyamphetamine
| (alpha-methyl,3,4-methylenedioxyphenethylamine,
| methylenedioxyamphetamine, MDA); | (1.1) Alpha-ethyltryptamine
| (some trade or other names: etryptamine;
| MONASE; alpha-ethyl-1H-indole-3-ethanamine;
| 3-(2-aminobutyl)indole; a-ET; and AET); | (2) 3,4-methylenedioxymethamphetamine (MDMA); | (2.1) 3,4-methylenedioxy-N-ethylamphetamine
| (also known as: N-ethyl-alpha-methyl-
| 3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
| and MDEA); | (2.2) N-Benzylpiperazine (BZP); | (3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA); | (4) 3,4,5-trimethoxyamphetamine (TMA); | (5) (Blank); | (6) Diethyltryptamine (DET); | (7) Dimethyltryptamine (DMT); | (8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP); | (9) Ibogaine (some trade and other names:
| 7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
| 6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
| indole; Tabernanthe iboga); | (10) Lysergic acid diethylamide; |
| (10.5) Salvia divinorum (meaning all parts of the plant | presently classified
botanically as Salvia divinorum, | whether growing or not, the
seeds thereof, any extract from | any part of that plant, and every compound,
manufacture, | salts, isomers, and salts of
isomers whenever the existence | of such salts, isomers, and salts of
isomers is possible | within the specific chemical designation, derivative, | mixture, or preparation of that plant, its
seeds or | extracts);
| (11) 3,4,5-trimethoxyphenethylamine (Mescaline); | (12) Peyote (meaning all parts of the plant presently | classified
botanically as Lophophora williamsii
Lemaire, | whether growing or not, the
seeds thereof, any extract from | any part of that plant, and every compound,
manufacture, | salts, derivative, mixture, or preparation of that plant, | its
seeds or extracts); | (13) N-ethyl-3-piperidyl benzilate (JB 318); | (14) N-methyl-3-piperidyl benzilate; | (14.1) N-hydroxy-3,4-methylenedioxyamphetamine
| (also known as N-hydroxy-alpha-methyl-
| 3,4(methylenedioxy)phenethylamine and N-hydroxy MDA); | (15) Parahexyl; some trade or other names:
| 3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
| dibenzo (b,d) pyran; Synhexyl; | (16) Psilocybin; | (17) Psilocyn; |
| (18) Alpha-methyltryptamine (AMT); | (19) 2,5-dimethoxyamphetamine
| (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA); | (20) 4-bromo-2,5-dimethoxyamphetamine
| (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
| 4-bromo-2,5-DMA); | (20.1) 4-Bromo-2,5 dimethoxyphenethylamine.
| Some trade or other names: 2-(4-bromo-
| 2,5-dimethoxyphenyl)-1-aminoethane;
| alpha-desmethyl DOB, 2CB, Nexus; | (21) 4-methoxyamphetamine
| (4-methoxy-alpha-methylphenethylamine;
| paramethoxyamphetamine; PMA); | (22) (Blank); | (23) Ethylamine analog of phencyclidine.
| Some trade or other names:
| N-ethyl-1-phenylcyclohexylamine,
| (1-phenylcyclohexyl) ethylamine,
| N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE; | (24) Pyrrolidine analog of phencyclidine. Some trade | or other names:
1-(1-phenylcyclohexyl) pyrrolidine, PCPy, | PHP; | (25) 5-methoxy-3,4-methylenedioxy-amphetamine; | (26) 2,5-dimethoxy-4-ethylamphetamine
| (another name: DOET); | (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine
|
| (another name: TCPy); | (28) (Blank); | (29) Thiophene analog of phencyclidine (some trade
| or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
| 2-thienyl analog of phencyclidine; TPCP; TCP); | (30) Bufotenine (some trade or other names:
| 3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
| 3-(2-dimethylaminoethyl)-5-indolol;
| 5-hydroxy-N,N-dimethyltryptamine;
| N,N-dimethylserotonin; mappine) ; . | (31) 1-Pentyl-3-(1-naphthoyl)indole | Some trade or other names: JWH-018; | (32) 1-Butyl-3-(1-naphthoyl)indole | Some trade or other names: JWH-073. | (e) Unless specifically excepted or unless listed in | another
schedule, any material, compound, mixture, or | preparation which contains
any quantity of the following | substances having a depressant effect on
the central nervous | system, including its salts, isomers, and salts of
isomers | whenever the existence of such salts, isomers, and salts of
| isomers is possible within the specific chemical designation: | (1) mecloqualone; | (2) methaqualone; and | (3) gamma hydroxybutyric acid. | (f) Unless specifically excepted or unless listed in | another schedule,
any material, compound, mixture, or |
| preparation which contains any quantity
of the following | substances having a stimulant effect on the central nervous
| system, including its salts, isomers, and salts of isomers: | (1) Fenethylline; | (2) N-ethylamphetamine; | (3) Aminorex (some other names:
| 2-amino-5-phenyl-2-oxazoline; aminoxaphen;
| 4-5-dihydro-5-phenyl-2-oxazolamine) and its
| salts, optical isomers, and salts of optical isomers; | (4) Methcathinone (some other names:
| 2-methylamino-1-phenylpropan-1-one;
| Ephedrone; 2-(methylamino)-propiophenone;
| alpha-(methylamino)propiophenone; N-methylcathinone;
| methycathinone; Monomethylpropion; UR 1431) and its
| salts, optical isomers, and salts of optical isomers; | (5) Cathinone (some trade or other names:
| 2-aminopropiophenone; alpha-aminopropiophenone;
| 2-amino-1-phenyl-propanone; norephedrone); | (6) N,N-dimethylamphetamine (also known as:
| N,N-alpha-trimethyl-benzeneethanamine;
| N,N-alpha-trimethylphenethylamine); | (7) (+ or -) cis-4-methylaminorex ((+ or -) cis-
| 4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine). | (g) Temporary listing of substances subject to emergency | scheduling.
Any material, compound, mixture, or preparation | that contains any quantity
of the following substances: |
| (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
| (benzylfentanyl), its optical isomers, isomers, salts,
| and salts of isomers; | (2) N-[1(2-thienyl)
| methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl),
| its optical isomers, salts, and salts of isomers. | (Source: P.A. 95-239, eff. 1-1-08; 95-331, eff. 8-21-07; | 96-347, eff. 1-1-10.)
|
Effective Date: 1/1/2011
|
|
|